相似文献
1
Physician-related factors involved in patient decisions to enroll onto cancer clinical trials.
J Oncol Pract. 2009 Mar;5(2):50-6. doi: 10.1200/JOP.0922001.
2
Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
Clin Breast Cancer. 2005 Apr;6(1):45-54. doi: 10.3816/CBC.2005.n.008.
3
Public attitudes regarding willingness to participate in medical research studies.
J Health Soc Policy. 2000;12(2):23-43. doi: 10.1300/J045v12n02_02.
4
Public motives and willingness to participate in first-in-human clinical trials in Saudi Arabia: A new era in the making.
J Infect Public Health. 2019 Sep-Oct;12(5):673-680. doi: 10.1016/j.jiph.2019.03.013. Epub 2019 Apr 18.
5
Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Clin Trials. 2020 Apr;17(2):184-194. doi: 10.1177/1740774520901514. Epub 2020 Feb 3.
6
Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
Gynecol Oncol. 2015 Jul;138(1):101-8. doi: 10.1016/j.ygyno.2015.04.033. Epub 2015 Apr 30.
7
The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
Prev Med. 1998 Sep-Oct;27(5 Pt 1):713-9. doi: 10.1006/pmed.1998.0349.
8
Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group.
J Cancer Surviv. 2009 Sep;3(3):137-47. doi: 10.1007/s11764-009-0093-2. Epub 2009 Jun 13.
9
Closing the divide: diverse populations and cancer survivorship.
Cancer. 2005 Dec 1;104(11 Suppl):2577-83. doi: 10.1002/cncr.21251.
10
Cancer patients' perceptions of factors influencing their decisions on participation in clinical drug trials: A qualitative meta-synthesis.
J Clin Nurs. 2019 Jul;28(13-14):2443-2461. doi: 10.1111/jocn.14785. Epub 2019 Mar 3.
引用本文的文献
1
Exploring Diabetes Clinical Trial Participation: A Diverse Group Interview Study.
Ther Innov Regul Sci. 2025 Aug 30. doi: 10.1007/s43441-025-00867-y.
2
Molecularly-Guided Cancer Clinical Trial Matching using FHIR and HL7 Clinical Quality Language: A Proof of Concept.
AMIA Annu Symp Proc. 2025 May 22;2024:359-367. eCollection 2024.
3
Representation of Native Hawaiian and Pacific Islander Individuals in Clinical Trials.
JAMA Netw Open. 2024 Oct 1;7(10):e2442204. doi: 10.1001/jamanetworkopen.2024.42204.
4
Is there a relationship between attitudes of general practitioners/family doctors and attitudes of their patients regarding industry-sponsored clinical investigations? A cross-sectional survey in a convenience sample of doctors and patients across nine European countries.
Croat Med J. 2024 Aug 31;65(4):313-327. doi: 10.3325/cmj.2024.65.327.
5
Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team.
Med Sci (Basel). 2024 Aug 14;12(3):39. doi: 10.3390/medsci12030039.
6
An intersectionality framework for identifying relevant covariates in health equity research.
Front Public Health. 2024 Mar 14;12:1286121. doi: 10.3389/fpubh.2024.1286121. eCollection 2024.
7
Predicting risk factors for pediatric mortality in clinical trial research: A retrospective, cross-sectional study using a Healthcare Cost and Utilization Project database.
J Clin Transl Sci. 2023 Sep 22;7(1):e211. doi: 10.1017/cts.2023.634. eCollection 2023.
8
Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved Populations.
Cancer Control. 2023 Jan-Dec;30:10732748231187829. doi: 10.1177/10732748231187829.
9
Evaluating the impact of patients' psychological and physical problems on their interest in participating in research at a cancer center with a rural catchment area.
Contemp Clin Trials. 2023 Aug;131:107245. doi: 10.1016/j.cct.2023.107245. Epub 2023 May 29.
10
Recruitment rates and strategies in exercise trials in cancer survivorship: a systematic review.
J Cancer Surviv. 2024 Aug;18(4):1233-1242. doi: 10.1007/s11764-023-01363-8. Epub 2023 Apr 6.
本文引用的文献
1
Provider roles in the recruitment of underrepresented populations to cancer clinical trials.
Cancer. 2007 Feb 1;109(3):465-76. doi: 10.1002/cncr.22436.
2
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital.
BMC Cancer. 2006 Nov 8;6:263. doi: 10.1186/1471-2407-6-263.
3
Cancer survivors information seeking behaviors: a comparison of survivors who do and do not seek information about cancer.
Patient Educ Couns. 2007 Mar;65(3):342-50. doi: 10.1016/j.pec.2006.08.015. Epub 2006 Oct 9.
4
Circumventing resistance to kinase-inhibitor therapy.
N Engl J Med. 2006 Jun 15;354(24):2594-6. doi: 10.1056/NEJMe068073.
5
Factors associated with participation in breast cancer treatment clinical trials.
J Clin Oncol. 2006 Apr 20;24(12):1860-7. doi: 10.1200/JCO.2005.03.8976.
6
Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors.
Cancer Detect Prev. 2006;30(1):24-33. doi: 10.1016/j.cdp.2005.12.001. Epub 2006 Feb 21.
7
Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials.
J Clin Oncol. 2005 Dec 20;23(36):9282-9. doi: 10.1200/JCO.2005.02.6245.
8
Clinical trial accrual among new cancer patients at a community-based cancer center.
Cancer. 2006 Jan 15;106(2):426-33. doi: 10.1002/cncr.21597.
9
Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey.
Arch Intern Med. 2005;165(22):2618-24. doi: 10.1001/archinte.165.22.2618.
10
Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.
Am J Surg. 2005 Oct;190(4):539-42. doi: 10.1016/j.amjsurg.2005.06.024.
Zotero 插件